Research p 8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth

[1]  D. Seachrist,et al.  Embryonic Expression of the Luteinizing Hormone β Gene Appears to Be Coupled to the Transient Appearance of p8, a High Mobility Group-related Transcription Factor* , 2003, The Journal of Biological Chemistry.

[2]  F. Itoh,et al.  Smad‐dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF‐β , 2002 .

[3]  M. Pankratz,et al.  Nutrient control of gene expression in Drosophila: microarray analysis of starvation and sugar‐dependent response , 2002, The EMBO journal.

[4]  S. Goruppi,et al.  Signaling pathways and late‐onset gene induction associated with renal mesangial cell hypertrophy , 2002, The EMBO journal.

[5]  J. Dagorn,et al.  The HMG-I/Y-related Protein p8 Binds to p300 and Pax2trans-Activation Domain-interacting Protein to Regulate thetrans-Activation Activity of the Pax2A and Pax2B Transcription Factors on the Glucagon Gene Promoter* , 2002, The Journal of Biological Chemistry.

[6]  R. Feil,et al.  p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis , 2002, Oncogene.

[7]  J. Dagorn,et al.  p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene , 2002, EMBO reports.

[8]  F. Itoh,et al.  Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta. , 2002, The EMBO journal.

[9]  Shuji Takahashi,et al.  Cloning and characterization of the Xenopus laevis p8 gene , 2001, Development, growth & differentiation.

[10]  F. Real,et al.  Genetic profile of 22 pancreatic carcinoma cell lines , 2001, Virchows Archiv.

[11]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Dagorn,et al.  Expression of the stress-induced p8 mRNA is transiently activated after culture medium change. , 2001, European journal of cell biology.

[13]  L. Giono,et al.  Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression. , 2001, The Biochemical journal.

[14]  X. Ding,et al.  MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. , 2001, Biochemical and biophysical research communications.

[15]  J. González-Ros,et al.  Human p8 Is a HMG-I/Y-like Protein with DNA Binding Activity Enhanced by Phosphorylation* , 2001, The Journal of Biological Chemistry.

[16]  C. Hansen,et al.  Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. , 2000, Cancer research.

[17]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[18]  J. Iovanna,et al.  Cloning and expression of the human p8, a nuclear protein with mitogenic activity. , 2001, European journal of biochemistry.

[19]  J. Iovanna,et al.  Structural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoter. , 1999, The Biochemical journal.

[20]  E. Hovig,et al.  Expression of a novel factor in human breast cancer cells with metastatic potential. , 1999, Cancer research.

[21]  J. Iovanna,et al.  Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. , 1999, Biochemical and biophysical research communications.

[22]  B. Simon,et al.  Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. , 1998, Cancer research.

[23]  J. Iovanna,et al.  Cloning and Expression of the Rat p8 cDNA, a New Gene Activated in Pancreas during the Acute Phase of Pancreatitis, Pancreatic Development, and Regeneration, and Which Promotes Cellular Growth* , 1997, The Journal of Biological Chemistry.

[24]  S. Dergham,et al.  Relationship of family cancer history to the expression of P53, P21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[25]  S. Goodman,et al.  Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.

[26]  F. Sarkar,et al.  Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[27]  S. Goodman,et al.  Tumor suppressive pathways in pancreatic cancer , 1997 .

[28]  T. Goodrow,et al.  Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. , 1996, Cancer research.

[29]  R. Reeves,et al.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. , 1996, Progress in nucleic acid research and molecular biology.

[30]  Teruhiko Yoshida,et al.  Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. , 1995, Cancer research.

[31]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[32]  P. Guillou,et al.  Biology of pancreatic cancer. , 1991, Gut.

[33]  B. Seed,et al.  A simple phase-extraction assay for chloramphenicol acyltransferase activity. , 1988, Gene.

[34]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[35]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .